Moods Disorders Completed Phase 1 Trials for Doxazosin (DB00590)

Also known as: Mood Disorders / Mood Disorder

IndicationStatusPhase
DBCOND0058256 (Moods Disorders)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01386177Pharmacological Interaction Between Doxazosin and Methylenedioxymethamphetamine (MDMA)Basic Science